Skip to main content

Rabeprazole (International)

In the US, Rabeprazole (rabeprazole systemic) is a member of the drug class proton pump inhibitors and is used to treat Barrett's Esophagus, Duodenal Ulcer, Duodenal Ulcer Prophylaxis, Erosive Esophagitis, GERD, Helicobacter Pylori Infection, Stomach Ulcer and Zollinger-Ellison Syndrome.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

A02BC04

CAS registry number (Chemical Abstracts Service)

0117976-89-3

Chemical Formula

C18-H21-N3-O3-S

Molecular Weight

359

Therapeutic Categories

Gastric acid secretion inhibitor

Treatment of peptic ulcer and gastro-oesophageal reflux disease (GORD)

Proton pump inhibitor (PPI)

Chemical Names

1H-Benzimidazole, 2-[[[4-(3-metoxypropoxy)-3-metyl-2-pyridinyl]-metyl]sulfinyl]-

2-[[[4-(3-metoxypropoxy)-3-metyl-2-pyridyl]metyl]sulfinyl]benzimidazole (WHO)

Foreign Names

Generic Names

Brand Names

Glossary

TermDefinition
BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Ph. Eur.European Pharmacopoeia
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.